Early Intervention for Dramatic Quality of Life Benefits
The American Diabetes Association recommends that testing to detect prediabetes and type 2 diabetes be considered in all adults without symptoms who are overweight or obese and have one or more additional risk factors for diabetes. Risk factors include having a parent, brother, or sister with diabetes, having high blood pressure, having a history of cardiovascular disease, as well as other risk factors. People who are overweight or obese, but without risk factors, should see their doctor for testing at age 45. Studies indicate that early lifestyle interventions for at-risk patients lower the probability of developing the disease by 58%, and these interventions can have dramatic quality of life benefits.(1)
Precision Medicine for Pre-diabetes
Polygenic panels that contain biomarkers related to increased susceptibility to developing type 2 diabetes in pre-diabetic patients have been identified. Having a tool to stratify patients according to risk is key to the success of any health management initiative. Polygenic panels provide such a tool.
The growing epidemic of type 2 diabetes is one of the leading causes of premature morbidity and mortality worldwide and the benefits of early intervention cannot be underestimated. The U.S. Department of Health and Human Services estimates that about one in four U.S. adults aged 20 years or older—or 57 million people—had prediabetes in 2007.
Diabetes Prevention, It’s What We Do
Preventing diabetes mellitus requires a multifactorial approach targeting multiple modifiable risk factors. Our clinical care includes assessment of nutrient blood serum levels and other biomarkers. Our proprietary expert system focuses on genetic variations found to influence the development of glucose dysregulation and insulin resistance.
We’ve collated a large body of research on preclinical diabetes and honed in on the findings that report preventive measures associated with genes regulating glucose homeostasis. With that foundation in place, we have developed a genomic-based program based on the principles promulgated by the NIH Diabetes Prevention Program (a major multicenter clinical research study) and designed a diabetes prevention program with an emphasis specific to your genetic makeup.
- Diabetes Prevention Program (DPP) Research Group., The Diabetes Prevention Program (DPP): description of lifestyle intervention. Diabetes Care. 2002 Dec;25(12):2165-71.